Ligand Pharmaceuticals (LGND) Enterprise Value (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ligand Pharmaceuticals | 4.55 Bn | 3.77 Bn | 48.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -309.01% |
| Dec 31, 2025 | 71.32% |
| Sep 30, 2025 | -171.21% |
| Jun 30, 2025 | -17.29% |
| Mar 31, 2025 | 18.45% |
| Dec 31, 2024 | -242.69% |
| Sep 30, 2024 | 67.06% |
| Jun 30, 2024 | 26.94% |
| Mar 31, 2024 | -82.37% |
| Dec 31, 2023 | 10.60% |
| Sep 30, 2023 | 13.03% |
| Jun 30, 2023 | 22.51% |
| Mar 31, 2023 | -33.41% |
| Dec 31, 2022 | -74.51% |
| Sep 30, 2022 | 17.93% |
| Jun 30, 2022 | 27.48% |
| Mar 31, 2022 | 40.20% |
| Dec 31, 2021 | -5.54% |
| Sep 30, 2021 | -7.08% |
| Jun 30, 2021 | 11.02% |
| Mar 31, 2021 | 17.51% |
| Dec 31, 2020 | 48.28% |
| Sep 30, 2020 | 1.83% |
| Jun 30, 2020 | -9.62% |
| Mar 31, 2020 | 30.94% |
| Dec 31, 2019 | 2.71% |
| Sep 30, 2019 | -282.70% |
| Jun 30, 2019 | 79.89% |
| Mar 31, 2019 | -922.39% |
| Dec 31, 2018 | -4.08% |
| Sep 30, 2018 | 36.45% |
| Jun 30, 2018 | 20.09% |
| Mar 31, 2018 | -2,742.51% |
| Dec 31, 2017 | 95.40% |
| Sep 30, 2017 | -17.17% |
| Jun 30, 2017 | -8.32% |
| Mar 31, 2017 | -12.99% |
| Dec 31, 2016 | -62.91% |
| Sep 30, 2016 | 19.05% |
| Jun 30, 2016 | 5.52% |
| Mar 31, 2016 | 43.46% |
| Dec 31, 2015 | -112.16% |
| Sep 30, 2015 | 48.04% |
| Jun 30, 2015 | -0.91% |
| Mar 31, 2015 | -6.34% |
| Dec 31, 2014 | 10.06% |
| Sep 30, 2014 | -714.27% |
| Jun 30, 2014 | 8.48% |
| Mar 31, 2014 | -58.03% |
| Dec 31, 2013 | -388.51% |
| Sep 30, 2013 | 44.77% |
| Jun 30, 2013 | -17.59% |
| Mar 31, 2013 | 59.32% |
| Dec 31, 2012 | -75.72% |
| Sep 30, 2012 | 20.70% |
| Jun 30, 2012 | 21.33% |
| Mar 31, 2012 | -29.86% |
| Dec 31, 2011 | -122.60% |
| Sep 30, 2011 | 23.35% |
| Jun 30, 2011 | 15.51% |
| Mar 31, 2011 | 57.97% |
| Dec 31, 2010 | -278.11% |
| Sep 30, 2010 | -17.34% |